Alice Zhou, MD, PhD

Medical Oncologist

Alice Zhou

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Siteman Cancer Center at Barnes-Jewish West County Hospital

Siteman Cancer Center at Barnes-Jewish West County Hospital

Medical Office Building 2, 10 Barnes West Drive, Creve Coeur, MO 63141

Expertise & Training

Video thumbnail for Alice Zhou, MD, PhD

Watch video on YouTube

Alice Zhou, MD, PhD

5 mins

Washington University medical oncologist Alice Zhou, MD, PhD, discusses what skin cancer patients can expect from their extended care team at Siteman Cancer Center.

To be able to help people when they go on this really difficult journey is really a priviledge for me.

Alice Zhou, MD, PhD

Clinical Expertise

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, WashU Medicine

Board Certification

  • 2019: American Board of Internal Medicine

Training

  • 2016 - 2019: Resident, Internal Medicine, Vanderbilt University, Nashville, TN
  • 2019 - 2022: Fellow, Hematology/Oncology, WashU Medicine, St. Louis, MO

Education

  • 2014: PhD, Cellular and Molecular Biology, University of Pennsylvania, Philadelphia, PA
  • 2016: MD, University of Pennsylvania, Philadelphia, PA

Research & Selected Publications

Research Interest

Use of translational immunotherapy to develop novel treatments for solid cancers; targeted therapy; biomarkers.

Research Publications

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial
Authors:

Campian JL, Le SB, Ghiaseddin A, one or more additional authors omitted Zhou AY, one or more additional authors omitted Tran DD

Journal & Year:

Nat Commun | 2026

Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series
Authors:

Morecroft R, Phillipps J, Barozinsky K, one or more additional authors omitted Zhou A

Journal & Year:

JAAD Case Rep | 2025

Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma
Authors:

Zhou AY, Marin ND, Afrin S, one or more additional authors omitted Fehniger TA

Journal & Year:

J Immunol | 2025

Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation
Authors:

Foltz JA, Tran J, Wong P, one or more additional authors omitted Zhou AY, one or more additional authors omitted Fehniger TA

Journal & Year:

Sci Immunol | 2024

Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation
Authors:

Cubitt CC, Wong P, Dorando HK, one or more additional authors omitted Zhou AY, one or more additional authors omitted Fehniger TA

Journal & Year:

J Clin Invest | 2024

Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
Authors:

Jacobs MT, Wong P, Zhou AY, one or more additional authors omitted Fehniger TA

Journal & Year:

Clin Cancer Res | 2023

BRAF/MEK Inhibition as a Bridge to Immunotherapy for Symptomatic BRAF V600 Melanoma Brain Metastases: A Case Series
Authors:

Strelnikov J, Zhou A, Butt O, Ansstas M , Ansstas G

Journal & Year:

J Natl Compr Canc Netw | 2023